Event ·Multi-source

Orchestra Bio 团队加入 OpenAI，扩展 AI 辅助药物发现业务

OpenAI 宣布收购生物科技公司 Orchestra Bio，其团队连同创始人 Ashoka Raj 加入 OpenAI。此次加入的目的是扩展 OpenAI 在 AI 辅助药物发现方向的工作。OpenAI 此前已在生命科学领域投入，如开发面向生物研究的模型和与科研机构合作，此次整合专门聚焦药物研发场景。

Current read

OpenAI 把 Orchestra Bio 整个团队收进来了，专门做 AI 药物发现，看来是要在生物制药这块下真功夫。

11 sources39° AI heatLast updated 2026/10/20 19:33:08

Evidence

11 sources

Primary sourceMark Chen (OpenAI 研究)

2026/10/20 19:33:08View source

Related source 1OpenAI

2026/10/20 18:10:16View source

Related source 2TestingCatalog

2026/10/20 18:21:43View source

Related source 3rohanpaul_ai

2026/10/20 18:58:27View source

Related source 4techcrunch

2026/10/20 20:35:10View source

Related source 5kimmonismus

2026/10/20 21:21:35View source

Related source 6IT之家

2026/10/20 22:51:11View source

Related source 7Tech in Asia

2026/10/21 06:21:20View source

Related source 8Decoder

2026/10/21 08:32:54View source

Related source 9Tanishq Abraham (论文推介)

2026/10/21 04:28:16View source

Related source 10Latent.Space

2026/10/19 15:03:00View source

Conflict check

Dedup data only shows that these sources discuss the same event, not that they agree. There is no structured supporting or refuting evidence yet, so no conflict is inferred automatically.

Open the story